TABLE 3.
Baseline ED treatment by sildenafil‐P use
| Variable | Sildenafil‐P use | |
|---|---|---|
| Never users (n = 928) | Sildenafil‐P users (n = 234) | |
| n (%) | n (%) | |
| Any prescription medication | 139 (14.98) | 85 (36.32) |
| Branded prescription tadalafil | 34 (24.46) | 19 (22.35) |
| Branded prescription vardenafil | 3 (2.16) | 5 (5.88) |
| Branded prescription sildenafil | 44 (31.65) | 49 (57.65) |
| Branded prescription avanafil | 1 (0.72) | 1 (1.18) |
| Generic prescription sildenafil | 64 (46.04) | 24 (28.24) |
| Generic prescription tadalafil | 10 (7.19) | 4 (4.71) |
| Other prescription medication | 2 (1.44) | 0 (0.00) |
| Injectables | 6 (0.65) | 5 (2.14) |
| Alternative medicine | 3 (0.32) | 3 (1.28) |
| Lifestyle changes | 69 (7.44) | 41 (17.52) |
| Penile implant | 3 (0.32) | 4 (1.71) |
| Penile vacuum or pump | 16 (1.72) | 9 (3.85) |
| Herbal treatments or supplements | 27 (2.91) | 15 (6.41) |
| Testosterone therapy | 5 (0.54) | 9 (3.85) |
| Other treatment | 53 (5.71) | 14 (5.98) |
| Never tried anything for ED | 640 (68.97) | 92 (39.32) |
| Medication use for comorbid health conditions | 577 (62.20) | 107 (45.70) |
ED, erectile dysfunction; sildenafil‐P, pharmacy medicine sildenafil.